12 月11 日，公司公告称，为推进股权激励计划，公司于12 月11日购买814 万股股份，每股均价为12.26 港元，总花费为9977 万港元，公司单日大额回购充分展现后续发展信心。 经营分析 Hilo 产品力逐渐得到验证，英美烟草促销力度持续加大。据BAT2025 年业绩预告，日本市场上BAT 积 极推进线上线下营销活动，产品品牌和性能引起消费者的强烈共鸣，来自传统卷烟和加热烟草消费者的 留存率约为50%。高留存率直接验证hilo 优秀的产品力，为后续烟弹起量奠定坚实基础。据BAT 官网， 近期hilo 于波兰市场上大幅提高优惠力度，Hilo 器具加两包烟弹仅售1 兹罗提，Hilo Plus 器具加两包烟 弹仅售79 兹罗提。依托BAT 完备的销售网络和足够的营销资源，后续Hilo 烟弹销售有望持续放量，为 思摩尔贡献核心盈利增量。 机构：国金证券 研究员：张杨桓/赵中平 事件简评 核心雾化业务持续修复，有望持续受益于欧美市场扩容。2024 年以来，美国监管部门持续加大对非法 电子烟的打击力度，非法产品的生存空间受到严重挤压。且FDA 官方表态谨慎支持扩大调味烟范围， 合规市场有望持续扩容。英法等国已全面 ...

国金证券主要观点如下： 事件简评 12月11日，公司公告称，为推进股权激励计划，公司于12月11日购买814万股股份，每股均价为12.26港 元，总花费为9977万港元，公司单日大额回购充分展现后续发展信心。 Hilo产品力逐渐得到验证，英美烟草促销力度持续加大 据BAT2025年业绩预告，日本市场上BAT积极推进线上线下（300959）营销活动，产品品牌和性能引起 消费者的强烈共鸣，来自传统卷烟和加热烟草消费者的留存率约为50%。高留存率直接验证hilo优秀的 产品力，为后续烟弹起量奠定坚实基础。据BAT官网，近期hilo于波兰市场上大幅提高优惠力度，Hilo 器具加两包烟弹仅售1兹罗提，Hilo Plus器具加两包烟弹仅售79兹罗提。依托BAT完备的销售网络和足 够的营销资源，后续Hilo烟弹销售有望持续放量，为思摩尔贡献核心盈利增量。 国金证券发布研报称，思摩尔国际(06969)作为头部烟草巨头核心供应商，且自营的开放式产品持续贡 献业绩增量，有望充分受益于欧美合规雾化市场扩容。海外新型烟草渗透率提升的长期趋势确定，公司 依托自身技术实力、量产能力深度绑定大烟草集团享受产业发展大趋势的优势地位突出。公司 ...

事件简评 12 月 11 日，公司公告称，为推进股权激励计划，公司于 12 月 11 日购买 814 万股股份，每股均价为 12.26 港元，总花费为 9977 万 港元，公司单日大额回购充分展现后续发展信心。 经营分析 Hilo 产品力逐渐得到验证，英美烟草促销力度持续加大。据 BAT2025 年业绩预告，日本市场上 BAT 积极推进线上线下营销活 动，产品品牌和性能引起消费者的强烈共鸣，来自传统卷烟和加热 烟草消费者的留存率约为 50%。高留存率直接验证 hilo 优秀的产 品力，为后续烟弹起量奠定坚实基础。据 BAT 官网，近期 hilo 于 波兰市场上大幅提高优惠力度，Hilo 器具加两包烟弹仅售 1 兹罗 提，Hilo Plus 器具加两包烟弹仅售 79 兹罗提。依托 BAT 完备的 销售网络和足够的营销资源，后续 Hilo 烟弹销售有望持续放量， 为思摩尔贡献核心盈利增量。 核心雾化业务持续修复，有望持续受益于欧美市场扩容。2024 年 以来，美国监管部门持续加大对非法电子烟的打击力度，非法产品 的生存空间受到严重挤压。且 FDA 官方表态谨慎支持扩大调味烟 范围，合规市场有望持续扩容。英法等国已 ...

Investment Rating - Industry rating is maintained as "Outperform the Market" [7] Core Insights - PMI reported a strong performance in the third quarter of 2025, with revenue reaching $30.3 billion, a year-on-year increase of 7.5%, and gross profit of $20.5 billion, up 12.1% [1] - Smoore achieved record quarterly revenue of $4.197 billion in Q3 2025, marking a 27.2% year-on-year growth [3] - The strong growth in PMI's reduced-risk products, particularly Nicotine Pouches, is a key driver of performance, with shipments increasing by 25.8% year-on-year [2] - Smoore's HNB (Heated Not Burned) business has seen significant growth, supported by successful product launches in international markets [4] Summary by Sections PMI Financial Performance - For the first three quarters of 2025, PMI's revenue was $30.3 billion, with a gross profit of $20.5 billion, and an adjusted diluted EPS of $2.24, reflecting a 17.3% increase [1] - In Q3 alone, revenue was $10.8 billion, with an operating profit of $4.3 billion, showing a 16.7% increase [1] PMI Product Performance - PMI shipped 940 million cans of oral tobacco products in the first three quarters, a 25.8% increase, with Q3 shipments at 313 million cans, up 20.2% [2] - Nicotine Pouches shipments reached 663 million cans in the first three quarters, a 44.0% increase [2] Smoore Financial Performance - Smoore's revenue for the first three quarters was $10.21 billion, a 21.8% increase, with adjusted profit at $1.182 billion, a slight increase of 0.1% [3] - The third quarter revenue of Smoore was a record $4.197 billion, with adjusted profit of $444 million, reflecting a 4.0% year-on-year growth [3] Smoore Product Performance - Smoore's HNB and e-cigarette businesses showed healthy growth, with strategic support for clients leading to increased product launches and compliance with regulations [4] - The introduction of new products and localized marketing efforts have contributed to the growth of Smoore's proprietary brand business [4] Regulatory Environment - Customs authorities in Ningbo and Huangpu seized 265,140 boxes of infringing "ZYN" products, which is expected to strengthen the legitimate supply chain and benefit the compliant oral tobacco industry [5]

Investment Rating - The industry investment rating is "Positive" [2] Core Viewpoints - The report highlights that British American Tobacco's (BAT) new tobacco products are showing signs of profitability recovery, particularly the HNB product Hilo, which is expected to drive future earnings growth [2][3] - For the first half of 2025, BAT reported revenues of £12.069 billion, a year-on-year decrease of 2.2%, but a 1.8% increase when adjusted for fixed exchange rates. New tobacco product revenues remained stable at £1.651 billion, accounting for 13.7% of total revenue [2][3] - The adjusted gross margin for new tobacco products increased by 2.5 percentage points to 59.6%, which is 10 percentage points higher than traditional cigarettes, indicating a potential for continued profitability improvement [2][3] Summary by Sections Revenue Performance - In H1 2025, BAT's revenue from new tobacco products was £1.651 billion, with a stable year-on-year performance and a 2.4% increase when adjusted for fixed exchange rates. This segment accounted for 13.7% of total revenue, up 0.3 percentage points year-on-year [2] - The overall tobacco market is expected to see a 2% decline in sales volume globally in 2025, while BAT anticipates its own growth to be between 1% and 2%, with new tobacco products expected to achieve mid-single-digit growth [2] Product Performance - The vaping segment saw revenues of £740 million in H1 2025, down 15.3% year-on-year, with a volume of 250 million units sold, a decrease of 12.9%. The decline in the US was attributed to illegal disposable products and inventory disruptions, while the European market is recovering due to improved regulatory conditions [2][3] - The HNB segment generated £440 million in revenue, with a slight year-on-year increase of 0.8%. Sales volume was 10.1 billion units, up 1.6%. The APMEA region showed an 8.7% increase in HNB sales, driven by significant contributions from Japan and Kazakhstan [3] - The oral tobacco segment experienced a revenue increase of 38.1% year-on-year, reaching £470 million, with a global market share increase of 4.4 percentage points. The US market saw a remarkable revenue growth of 372% year-on-year, driven by the successful nationwide launch of Velo Plus [4] Market Outlook - The report emphasizes the potential for HNB products to continue driving growth, with a focus on product iteration and market expansion. Key companies to watch include Smoore International, China National Tobacco Corporation, and core suppliers like Xianhe Co. and Yingqu Technology [4]

Summary of Smoore International and the E-Cigarette Industry Update Company and Industry Overview - **Company**: Smoore International - **Industry**: E-Cigarette and Vapor Products Key Points and Arguments 1. **Revenue Performance**: Smoore International reported an 18% year-on-year increase in revenue for the first half of 2025, with both ODM business and free brand business showing strong growth, particularly among small clients [2][5] 2. **U.S. Market Recovery**: The enforcement of regulations against non-compliant disposable e-cigarettes in the U.S. is expected to clear the market of non-compliant products, creating a better environment for compliant products and aiding Smoore's business recovery [3][7] 3. **European Market Changes**: The implementation of a ban on disposable e-cigarettes in Europe starting June 1, 2025, is anticipated to increase the market share of compliant products, which is favorable for Smoore in the long term [4][7] 4. **Profit Decline Factors**: Smoore's profit decreased by 21% to 35% in the first half of 2025, primarily due to increased equity incentive costs and legal-related expenses, with equity incentive costs expected to rise by over 300 million yuan for the year [5][12] 5. **New Product Trials in Japan**: The new product Hilo, developed in collaboration with British American Tobacco, has shown optimistic trial results in Sendai, Japan, with a high user satisfaction rate and a significant conversion rate from traditional smokers [6][7] 6. **Future Growth Trends**: The HNB (Heat-Not-Burn) market is expected to grow, with favorable conditions in the U.S. and Europe, and successful product trials in Japan indicating a positive outlook for Smoore's future [7][10] 7. **Impact of Tariffs on Indonesian Factory**: The tariff issues related to the Indonesian factory are expected to have a limited impact on overall performance due to high product markup and low unit prices, as the products are considered addictive consumer goods [8][12] 8. **Sales Performance in Japan**: The overall sales situation in Japan is optimistic, with expectations of meeting annual performance guidance despite 2025 not being a high-profit year [9][10] 9. **Traditional E-Cigarette Market Trends**: The traditional e-cigarette market in the U.S. and Europe is showing marginal improvement, indicating a positive trend in both policy and operational aspects [10][12] 10. **THC and Medical Aesthetics Growth**: The THC vaporization products are stabilizing, and related fields such as medical aesthetics are showing promising growth prospects, potentially providing new growth opportunities for Smoore [11][12] Additional Important Insights - **Stock Volatility and Investment Value**: Despite lower profits in 2025, Smoore's long-term investment value remains significant, warranting close attention from investors [12]